Axonal injury mediated by neuronal p75NTR/TRAF6/JNK pathway contributes to cognitive impairment after repetitive mTBI

Exp Neurol. 2024 Feb:372:114618. doi: 10.1016/j.expneurol.2023.114618. Epub 2023 Nov 27.

Abstract

Repetitive mild traumatic brain injury (rmTBI) is one of the leading causes of cognitive disorders. The impairment of axonal integrity induced by rmTBI is speculated to underlie the progression of cognitive dysfunction. However, few studies have uncovered the cellular mechanism regulating axonal impairment. In this study, we showed that after rmTBI, the activation of neuronal p75NTR signaling contributes to abnormal axonal morphology and impaired axonal transport, which further leads to cognitive dysfunction in mice. By neuron-specific knockdown of p75NTR or treatment with p75NTR inhibitor LM11A-31, we observed better recovery of axonal integrity and cognitive function after brain trauma. Further analysis revealed that p75NTR relies on its adaptor protein TRAF6 to activate downstream signaling via TAK1 and JNK. Overall, our results provide novel insight into the role of neuronal p75NTR in axonal injury and suggest that p75NTR may be a promising target for cognitive function recovery after rmTBI.

Trial registration: ClinicalTrials.gov NCT03069014.

Keywords: Axonal injury; Cognitive impairment; p75NTR; rmTBI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons
  • Brain Concussion* / complications
  • Cognitive Dysfunction* / etiology
  • Disease Models, Animal
  • MAP Kinase Signaling System
  • Mice
  • Mice, Inbred C57BL
  • TNF Receptor-Associated Factor 6

Substances

  • TNF Receptor-Associated Factor 6

Associated data

  • ClinicalTrials.gov/NCT03069014